| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000018901 |
| Receipt No. | R000021873 |
| Official scientific title of the study | The safety and efficacy of radiofrequency ablation and cryoablation in patients with atrial fibrillation (AF) under anticoagulant therapy with apixaban |
| Date of disclosure of the study information | 2015/09/03 |
| Last modified on | 2017/09/29 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | The safety and efficacy of radiofrequency ablation and cryoablation in patients with atrial fibrillation (AF) under anticoagulant therapy with apixaban | |
| Title of the study (Brief title) | The safety and efficacy of radiofrequency ablation and cryoablation in patients with atrial fibrillation (AF) under anticoagulant therapy with apixaban(J-HIT Study) | |
| Region |
|
|
| Condition | ||
| Condition | atrial fibrillation | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Comparing radiofrequency ablation and cryoablation in patients with AF taking apixaban, and demonstrate the safety and efficacy of both therapies. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Composite of major bleedings and thromboembolism during perioperative period and within 4 weeks after the surgery. |
| Key secondary outcomes | Recurrence of AF during the follow-up period (because the presence or absence of recurrence may be associated with the development of embolic events), non-major bleeding, pericardial effusions not requiring drainage. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Cluster |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Apixaban_radiofrequency ablation | ||
| Interventions/Control_2 | Apixaban_cryoablation | ||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Patients who are indicated for catheter ablation for drug-resistant non-valvular paroxysmal AF in the Japanese Heart Rhythm Society Guidelines
2)Patients who undergo the first catheter ablation while taking apixaban 3)Patients of age between 20 and 85 years 4)Patients for whom consent for participation in this study have been obtained in writing |
|||
| Key exclusion criteria | Patients with a history of hypersensitivity to the components of apixaban.
Patients with clinically significant bleeding symptoms. Patients with blood clotting defect and liver disease at clinically significant bleeding risk. |
|||
| Target sample size | 260 | |||
| Research contact person | |
| Name of lead principal investigator | Kenzo Hirao |
| Organization | Tokyo Medical and Dental University |
| Division name | Heart Rhythm Center |
| Address | 1-5-45, Yushima, Bunkyo-ku, Tokyo |
| TEL | 03-5803-5231 |
| 0160.cvm@tmd.ac.jp | |
| Public contact | |
| Name of contact person | Atsuhiko Yagishita |
| Organization | Tokyo Medical and Dental University |
| Division name | Department of Advanced technology in medicine |
| Address | 1-5-45, Yushima, Bunkyo-ku, Tokyo |
| TEL | 03-5803-5231 |
| Homepage URL | |
| atsuhikoyagishita.cvm@tmd.ac.jp | |
| Sponsor | |
| Institute | Tokyo Medical and Dental University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Bristol-Myers Squibb |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | さいたま赤十字病院(埼玉県)、土浦協同病院(茨城県)、横須賀共済病院(神奈川県)、武蔵野赤十字病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000021873 |